|
CA2297011C
(en)
*
|
1997-07-22 |
2007-01-30 |
Shionogi & Co., Ltd. |
Sulfonamide derivatives as therapeutic or prophylactic agent for glomerulopathy
|
|
KR100352316B1
(ko)
|
1997-07-31 |
2002-09-12 |
더 프록터 앤드 갬블 캄파니 |
메탈로프로테아제억제제로서사용되는술포닐아미노치환히드록삼산유도체
|
|
IL127496A0
(en)
*
|
1997-12-19 |
1999-10-28 |
Pfizer Prod Inc |
The use of MMP inhibitors for the treatment of ocular angiogenesis
|
|
US6410580B1
(en)
|
1998-02-04 |
2002-06-25 |
Novartis Ag |
Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
|
|
RU2208609C2
(ru)
|
1998-02-04 |
2003-07-20 |
Новартис Аг |
Сульфониламинопроизводные, которые ингибируют разлагающие матрикс металлопротеиназы
|
|
US6075136A
(en)
*
|
1998-02-17 |
2000-06-13 |
Incyte Pharmaceuticals, Inc. |
Prostate-associated serine protease
|
|
US6492394B1
(en)
|
1998-12-22 |
2002-12-10 |
Syntex (U.S.A.) Llc |
Sulfonamide hydroxamates
|
|
US6762178B2
(en)
|
1999-01-27 |
2004-07-13 |
Wyeth Holdings Corporation |
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6200996B1
(en)
|
1999-01-27 |
2001-03-13 |
American Cyanamid Company |
Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
|
|
US6225311B1
(en)
|
1999-01-27 |
2001-05-01 |
American Cyanamid Company |
Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
|
|
US6946473B2
(en)
|
1999-01-27 |
2005-09-20 |
Wyeth Holdings Corporation |
Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
|
|
US6313123B1
(en)
|
1999-01-27 |
2001-11-06 |
American Cyanamid Company |
Acetylenic sulfonamide thiol tace inhibitors
|
|
US6326516B1
(en)
|
1999-01-27 |
2001-12-04 |
American Cyanamid Company |
Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6340691B1
(en)
|
1999-01-27 |
2002-01-22 |
American Cyanamid Company |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
|
|
US6277885B1
(en)
|
1999-01-27 |
2001-08-21 |
American Cyanamid Company |
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6753337B2
(en)
|
1999-01-27 |
2004-06-22 |
Wyeth Holdings Corporation |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
|
|
BR0007784A
(pt)
|
1999-01-27 |
2002-02-05 |
American Cyanamid Co |
Composto, método para inibir mudanças patológicas mediadas pela enzima que converte o tnf-alfa (tace) em um mamìfero, composição farmacêutica, e, processo para preparar um composto
|
|
KR20010102486A
(ko)
|
1999-03-03 |
2001-11-15 |
데이비드 엠 모이어 |
알케닐- 및 알키닐-함유 메탈로프로테아제 저해제
|
|
HK1044935A1
(zh)
|
1999-03-03 |
2002-11-08 |
The Procter & Gamble Company |
双异取代的金属蛋白酶抑制剂
|
|
US6696456B1
(en)
*
|
1999-10-14 |
2004-02-24 |
The Procter & Gamble Company |
Beta disubstituted metalloprotease inhibitors
|
|
JP2005507937A
(ja)
|
2001-11-01 |
2005-03-24 |
ワイス・ホールディングズ・コーポレイション |
マトリックスメタロプロテイナーゼおよびｔａｃｅ阻害剤としてのアレンアリールスルホンアミドヒドロキサム酸
|
|
PE20030701A1
(es)
|
2001-12-20 |
2003-08-21 |
Schering Corp |
Compuestos para el tratamiento de trastornos inflamatorios
|
|
US7504537B2
(en)
|
2001-12-27 |
2009-03-17 |
Dainippon Sumitomo Pharma Co., Ltd. |
Hydroxamic acid derivative and MMP inhibitor containing the same as active ingredient
|
|
EP1511488B1
(en)
|
2002-06-12 |
2013-05-22 |
Symphony Evolution, Inc. |
Human adam-10 inhibitors
|
|
US7199155B2
(en)
|
2002-12-23 |
2007-04-03 |
Wyeth Holdings Corporation |
Acetylenic aryl sulfonate hydroxamic acid TACE and matrix metalloproteinase inhibitors
|
|
EP2106445A2
(en)
*
|
2006-12-01 |
2009-10-07 |
Loma Linda University Medical Center |
Inhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration
|
|
EP3860608A1
(en)
|
2018-10-04 |
2021-08-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Egfr inhibitors for treating keratodermas
|